Introduction
Over the past ten years, more than 30,000 manuscripts have been published worldwide, demonstrating D is an epiphenomenon that coincides with poor health outcomes (3) , and that the correction of vitamin D deficiency has no beneficial effects (3) . They also claim that conducting randomized controlled trials (RCTs) searching for vitamin D-dependent health outcomes is futile (4), but their meta-analyses were far from satisfactory because of the bias of selection of studies.
In contrast, other reviews, original studies, and meta-analyses strongly pointed towards vitamin D as having significant beneficial effects and an important micronutrient component in the prevention of diseases (5) (6) (7) (8) (9) (10) . In fact, is it not surprising, when general practitioners (GPs) review scientific papers
showing effects of vitamin D on reducing the risks of cardiovascular disease, stroke, heart failure, cancer, diabetes, autoimmune diseases, infections, secondary to having year-around, higher 25 A similar level of skepticism should be maintained when strong statements negating pleiotropic benefits of vitamin D using small-scaled, poorly designed and conducted short-term RCTs, and meta-analyses with an inherent selection bias in favor of conclusions (4, 5, 11) . In spite of the confusion created in the scientific and clinical literature, the consumption of vitamin D supplements has continued to increase (12). In certain populations, such supplementation have led to a modest increase of serum 25(OH)D concentrations (13) .
The concerns about adverse effects of vitamin D, in particular, increased risk for hypercalcemia, nephrocalcinosis, and kidney stones have kept some away from taking supplements. Furthermore, the negative experience gained through historical trends from other vitamins (e.g., vitamin A, C and E) and potential vitamin D "toxicity," may have increased their reluctance.
Despite criticisms, vitamin D is one of the most cost-effective micronutrient supplements, that leads to improving overall human health (5) (6) (7) (8) (9) (10) 14) . During the past decade, a significant progress has been made in reference to understanding of the biology and pathophysiology of vitamin D and its metabolic pathways (5-10,14-16). These cumulative evidence have changed the views of scientists working in this field and those clinicians prescribing vitamin D. This has changed the paradigm from the "bone-centric" approaches to pleiotropic conceptions and approaches (15) (16) .
While the number of publications and data related to vitamin D has been increasing markedly, the gap of knowledge on the 25(OH)D concentration expected to capture all possible pleiotropic effects (or even a single benefit) as well as the vitamin D doses needed to achieve this is widening. Further, lack of consensus of contradictory claims and recommendations provided by various published guidelines (15- 19) make decisions difficult or problematic, at least in some clinical conditions. Finally, the term "sufficiency" has led to confusion and endless debates between scientists and clinicians focused on "skeletal benefits" (17, 19) and those examining extra-skeletal vitamin D actions (5) (6) (7) (8) (9) (10) 15, 16) . Despite controversies, it seems important to look at the big picture and the pleiotropic actions with a balanced approach that would help overall human health of millions of people.
Vitamin D: A classic perspective in brief
Vitamin D is a fat-soluble vitamin; the term "vitamin D" refers to both ergocalciferol (vitamin D2) and cholecalciferol (vitamin D3), which are formed from their respective pro-vitamins, ergosterol and 7-dehydrocholesterol (7-DHC). The predominant natural source of vitamin D3 in humans is production in the skin where 7-DHC follows a two step-reaction involving ultraviolet-B (UV-B) irradiation to form previtamin D3 followed by a subsequent thermal isomerization to vitamin D3 (20) . Both vitamin D3 and vitamin D2 may be obtained in a lesser extent from varied diet and in more significant amounts from fortified foods and supplements. Fish liver oil, fatty fish or egg yolks contain higher amounts of vitamin D3 compared to other food products, however even varied diet cannot be considered as effective source to provide recommended daily doses. Vitamin D2 may be synthetized in plants and mushrooms involving UV-B action on ergosterol (21) . Cultivated mushrooms contain lower amounts of vitamin D2 than wildgrown, but if they are exposed to UV-B the amount of vitamin D2 increases (22) . Dietary vitamin D is absorbed predominantly in the small intestine via chylomicrons which enter the lymphatic system that drains into the superior vena cava. In tissues, 1,25(OH)2D dissociate from DBP, and binds to intracellular vitamin D receptors (VDR), which triggers several ubiquitous metabolic actions in tissues and organs. The main function of 1,25(OH)2D is to maintain a tight calcium and phosphorus homeostasis in the circulation. This is also modulated by parathyroid hormone (PTH), and fibroblast growth factor (FGF-23) (23) (24) (25) (26) (27) .
In humans, serum calcium concentration is maintained at a very narrow range of about 2.45-2.65 mmol/L. Consequently, when the blood ionized calcium concentration decreases below the normal range, a series of anti-hypocalcemic events will occur to restore calcium levels back to the physiologic range (27) . The main target tissues of 1,25(OH)2D actions are, the intestine, kidneys and bone. In the kidneys, 1,25(OH)2D stimulates PTH-dependent tubular reabsorption of calcium. PTH itself increases the conversion of 25(OH)D to 1,25(OH)2D in the proximal renal tubules (23) (24) (25) (26) (27) .
In the skeletal tissues, 1,25(OH)2D and PTH works in conjunction to control bone turnover. 1,25(OH)2D
interacts with the intra-cellular VDR in osteoblasts, increasing the genomic expression of several genes, especially receptor-activating nuclear factor ligand (RANKL). This ligand interacts with its receptor, RANK on monocytes lineage, inducing them to aggregate to form multinucleated osteoclasts (28) (29) (30) . Mature osteoclasts, after binding on to bone surfaces, release collagenases and hydrochloric acid, leading to degradation of collagen and releasing calcium back into the micro-environment, and consequently release calcium and phosphorus into the bloodstream (28) (29) (30) .
In the intestine, 1,25(OH)2D enhances calcium and phosphorus absorption. From a classic perspective, vitamin D deficiency disturbs bone metabolism that manifest as rickets in children, and osteomalacia in adults. Both diseases are caused by the impaired mineralization of bone due to an inadequate calcium-phosphate product due to PTH's action on the kidneys causing phosphaturia (6, 7, 9, 23, (25) (26) (27) 32) .
Vitamin D appeared to be critically important during the evolution of vertebrates, when amphibians moved out from the sea to land. In evolutionary terms, vitamin D is one of the oldest hormones, that is also produced by some of the earliest phytoplankton life forms (33, 34 It is known that the local production of 1,25(OH)2D followed by its binding to VDR is responsible for upregulation of approximately 2,000 genes that are involved in many metabolic pathways (29, 33) .
Plausibly, these are responsible for many of the non-calcemic benefits ascribed to vitamin D (5-10, 28, 29, 45,46) . It was evidenced that 1,25(OH)2D not only modulates cellular growth and differentiation, but also enhances the immune system (e.g., production of beta-defensin and cathelicidin, and modulation of production of anti-inflammatory cytokines: IL-4, IL-5) (7, 9, 45-52). In addition, it also increases the lymphocytic activity and stimulates insulin production (7, 9, 45, 46) . These findings help explaining many of the vitamin D actions and its association with the reduction of the risk of several diseases.
Vitamin D has shown a strong immunomodulatory capacity; high VDR levels have been reported in macrophages, dendritic cells, T lymphocytes, and B lymphocytes supports the conception of its fundamental role in combating bacteria, and preventing both autoimmune diseases and chronic inflammatory states (47) (48) (49) (50) . The available evidence of extra-skeletal vitamin D actions and related health benefits is growing (5, 7, 9, . Indisputably, 25(OH)D availability for endocrine, autocrine and paracrine pathways appeared crucial to lower the risks of cancers, autoimmune diseases (e.g., multiple sclerosis, type 1 diabetes, etc.), asthma and recurrent wheezing, CVD and stroke, systemic lupus erythematosus, atopic dermatitis, neurocognitive dysfunction including Alzheimer's disease, autism, infectious diseases including influenza and tuberculosis, pregnancy complications, type 2 diabetes, falls, osteoporosis and fractures, rickets, osteomalacia and others (5, 7, 9, , as well as the all-cause mortality (5, (64) (65) (66) (67) (68) .
Science needs to be balanced, so results from a review of 290 cohorts and 172 RCT (3), which included vitamin D and/or its metabolites and showed no major health benefits, should be kept in mind. On the other hand, in addition to the selection bias, most of the studies included to abovementioned review
were not specifically designed with vitamin D-related hard end points. Moreover, conclusions of this paper are very difficult to apply on an individual basis, where the need for vitamin D supplementation may be obvious. It should be highlighted that, in terms of everyday practice, the selection of adequate recommendation from a variety of available vitamin D supplementation guidelines depends on several factors, including clinical and environmental (15, 79) . Moreover, the differences related to latitude of residence, sunlight exposure, skin pigmentation, dietary practices, clothing and cultural habits, health care system, and many other population-specific factors, needs to be considered in making uniform guidelines (45, 53, 58, 73, (76) (77) (78) .
Vitamin D: minimum, maximum, optimum
Therefore, for the general population, otherwise considered as healthy, the selection of a guideline for vitamin D supplementation should be specific for age group, body weight, ethnicity (skin type), and latitude of residence. The IOM guidelines were commissioned by the United States and Canadian
Governments for public health purposes and not to use as clinical practice guidance, for the population living in North America (19) . Further, the IOM guidelines were established based on evidence that only focused on calcium-phosphate metabolism and bone health requirements (19) . Consequently, these IOM bone-centric guidelines should be considered, to some extent, as suitable for bone health, and most likely, the IOM recommendations utility is limited to population living in North America. Further, the IOM recommendations cannot be used as a guidance for treating patients.
Considering the above statements, the age-, body weight-and latitude-dependent recommendations seem as sine qua non or at least a more rational tool counteracting vitamin D deficiency at the national or regional level. It is of concern that certain diagnostic laboratories have adapted IOM cut-off points (19) in their 25(OH)D reporting, is a major mistake, which is not only misleading but also harmful to some patients. 
Recommendations for patients suffering from a disease
For an individual patient suffering from a disease, a wise choice of vitamin D recommendations should rely on the specificity of a particular disease that coincides with or is a result of vitamin D deficiency.
The recently published "Global Consensus Recommendations on Prevention and Management of
Nutritional Rickets" is a good example and fair postulate, because these guidelines were established only for this single specific disease, and based on the available evidence for nutritional rickets risk factors, course and therapy of the disease, its prevalence and incidence (86) . 
Less is sometimes more beneficial
An increasing number of over-the-counter vitamin D supplements available in pharmacies and through the Internet accompanied by media campaigns and product advertisements raised worries in medical community about vitamin D safety. In fact, because of the advertising tactics/errors, some consumers may believe miracles that the intake of more vitamin D equals more health benefits. While the latter is not necessarily true, such behavior can lead to overdosing. If used inappropriately, the long term selfadministration of vitamin D may lead to hypercalcemia and hypercalciuria (94) . Thus, the medical community and public health policy makers should be alerted and take proactive actions to minimize such hazards due to ignorance and marketing tactics. Educating consumers and addressing important issues such as efficacious dosage are recommended (94) .
A simple and effective tool to help prevent uncontrolled overuse of vitamin D for healthy population is a guideline for an upper tolerable intake values (upper limit; UL) (16, 19, 76, 78, 95) . Surprisingly, the upper limit values reported so far are generally agreeable for a given age irrespective of source of reference, Table 2 .
Further, the dose of 10,000 IU/d was also found as the no-observed-adverse-effect level (NOAEL) elucidating vitamin D safety limits (16, 19) .
Vitamin D: the ominous J / U shape curve for health outcomes:
There have been a number of studies that evaluated association between serum 25(OH)D concentration and the chronic illnesses or mortality (96) . It is important to note that physiological 25(OH)D concentrations (i.e., between 30 and 50 ng/mL) are associated with several pleiotropic health benefits and all-cause mortality risk reduction. Nevertheless, obtaining and maintaining higher 25(OH)D concentrations than that above recommended is not advisable; more is not always better. Self-administration of vitamin D, particularly parenteral doses, is not a panacea for treating diseases nor for reducing the risk of death, and caution is advised for use of vitamin D doses in amounts higher than that recommended for the general population. The exception is a laboratory confirmed vitamin D deficiency, which should be treated with short-term therapeutic doses under a supervision of a physician.
Can higher doses of vitamin D be toxic?
Vitamin D toxicity remains a concern for physicians and government public health agencies. Although 
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